AC Immune
Price & Volume
Stats
See more52W Range | $1.42-$3.88 |
Market Cap | $290.7M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $28.9M |
Revenue Growth (YoY) | 90.1% |
Gross Profit (12 Mos) | -$34M |
Diluted EPS | -$0.67 |
News
See moreYahoo Finance • 29 days ago
AC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway
Yahoo Finance • 2 months ago
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
Yahoo Finance • 6 months ago
AC Immune Reports Further Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
Yahoo Finance • 6 months ago
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025
About
CEO | Dr. Andrea Pfeifer Ph.D. |
CFO | Mr. Christopher Roberts |
Address | Building B, Lausanne, Switzerland, 1015 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 133 |
